GCG and congenital isolated hyperinsulinism: Several drugs not approved for use in the treatment of CHI have been utilized: mostly somatostatin analogues (octreotide and lanreotide), but also calcium channel blockers, mTOR inhibitors (sirolimus), and reconstituted glucagon (1, 5).